Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Melina Verso"'
Publikováno v:
Haematologica, Vol 105, Iss 3 (2020)
Randomized clinical trials have evaluated the role of anticoagulants in the prevention of venous thromboembolism (VTE) in ambulatory cancer patients treated with chemotherapy. This meta-analysis is aimed at providing an updated evaluation of the effi
Externí odkaz:
https://doaj.org/article/a9d2c39a53894a6bb14f7cc1d02bef80
Autor:
Michela Giustozzi, Maria Cristina Vedovati, Melina Verso, Luca Scrucca, Serenella Conti, Paolo Verdecchia, Giulio Bogliari, Lucia Pierpaoli, Giancarlo Agnelli, Cecilia Becattini
Publikováno v:
Data in Brief, Vol 23, Iss , Pp - (2019)
The data presented in this article are related to the research article entitled “Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study” [1]. This article unveils original data
Externí odkaz:
https://doaj.org/article/4eab1064ab3c49f5a7dbfdbbff16c099
Autor:
Davide Imberti, Giancarlo Agnelli, Walter Ageno, Marco Moia, Gualtiero Palareti, Riccardo Pistelli, Romina Rossi, Melina Verso
Publikováno v:
Haematologica, Vol 93, Iss 2 (2008)
Background Clinical characteristics and management of acute deep vein thrombosis and pulmonary embolism (PE) have been reported to be different in patients with and without cancer. The aim of this paper was to provide information on clinical characte
Externí odkaz:
https://doaj.org/article/c9e1f18540304c6b9d024b111bc35f9b
Publikováno v:
Internal and Emergency Medicine.
Publikováno v:
Seminars in Oncology.
Autor:
Cecilia Becattini, Giancarlo Agnelli, Melina Verso, Rupert Bauersachs, Menno V. Huisman, Andrés Muñoz, Mario Mandalà, Giorgio Vescovo
Publikováno v:
European Journal of Cancer, 148, 371-381. ELSEVIER SCI LTD
Background: Whether concomitant administration of anticancer agents influences the efficacy and safety of oral anticoagulants in patients treated for cancer-associated venous thromboembolism (VTE) is undefined. The pharmacological interaction between
Autor:
Alberto Carmona-Bayonas, Melina Verso, Manuel Sánchez Cánovas, Jaime Rubio Pérez, Marta García de Herreros, Purificación Martínez del Prado, Isaura Fernández Pérez, Teresa Quintanar Verduguez, Berta Obispo Portero, Vanessa Pachón Olmos, David Gómez, Laura Ortega, Marta Serrano Moyano, Elena M. Brozos, Mercedes Biosca, Maite Antonio Rebollo, Lucía Teijeira Sanchez, Carolina Hernández Pérez, José David Cumplido Burón, Nieves Martínez Lago, Estefanía García Pérez, Jose Muñoz Langa, Pedro Pérez Segura, Eva Martínez de Castro, Paula Jimenez-Fonseca, Giancarlo Agnelli, Andrés Muñoz
Publikováno v:
THROMBOSIS AND HAEMOSTASIS
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Thrombosis and haemostasis
r-FISABIO. Repositorio Institucional de Producción Científica
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Thrombosis and haemostasis
r-FISABIO. Repositorio Institucional de Producción Científica
BACKGROUND: Venous thromboembolism (VTE) is a common complication in cancer patients. Much of its morbidity stems from the development of fatal pulmonary embolisms (PE). Little is known about the factors involved in clot stability, with angiogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39ca449efdd7b5e757437bdd106d877
http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1816-8347.pdf
http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1816-8347.pdf
Autor:
Melina Verso, Giancarlo Agnelli, Andrés Munoz, Jean M. Connors, Olivier Sanchez, Menno Huisman, Benjamin Brenner, Gualberto Gussoni, Alexander T. Cohen, Cecilia Becattini
Publikováno v:
European Journal of Cancer, 165, 136-145. ELSEVIER SCI LTD
Background: Patients with cancer-associated venous thromboembolism (VTE) have a high risk of VTE recurrence and anticoagulant treatment-related bleeding, but the correlation of these risks with the cancer stage is unclear.Methods: We evaluated the ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afaece080c8a0f47851919392d0d39f7
https://hdl.handle.net/1887/3563148
https://hdl.handle.net/1887/3563148
Publikováno v:
Trends in Cardiovascular Medicine.
Venous thromboembolism (VTE), which includes pulmonary embolism and deep vein thrombosis, is a leading cause of morbidity and mortality in patients with cancer. Based on accumulating evidence, the prophylaxis and treatment of cancer-associated VTE ha
Autor:
Giancarlo Agnelli, Melina Verso
Publikováno v:
Thrombosis Research. 191:S123-S127
Approximately one-fifth of all cases of venous thromboembolism (VTE) are related to cancer. VTE complications may have a substantial impact on prognosis, quality of life and care in patients with cancer. Patients with cancer-related VTE are at increa